LIAISON Helicobacter Antigen, LIAISON Helicobacter Antigen Control Set
Helicobacter Pylori. 510(k) K181464, from DiaSorin, Inc. (Stillwater, MN). Product code LYR, class 1.
As of Nov 21, 2026, K181464 is an FDA 510(k) held by DiaSorin, Inc., substantially equivalent on Aug 31, 2018 after 88 days, with no recalls tied to it in FDA's recall database.
- Review time: 88 days
- Recalls: 0
The LIAISON® Helicobacter Antigen assay is a chemiluminescent immunoassay (CLIA) intended for the qualitative determination of Helicobacter pylori (H. pylori) antigen in human stool. The test is an aid in the diagnosis of patients suspected of H. pylori infection and to measure post therapy response from patients who have discontinued therapy for at least 4 weeks.
- Premier Platinum Hpsa Plus, Models 601396, 601480K053335 · Meridian Bioscience, Inc. · Mar 10, 2006
- LIAISON H. pylori IgG, LIAISON H. pylori IgG Control SetK161139 · DiaSorin, Inc. · Jul 22, 2016
- Hp Detect™ Stool Antigen ELISAK232892 · Biomerica, Inc. · Dec 15, 2023
- Premier HpSA Flex (619096)K230901 · Meridian Bioscience, Inc. · Jul 3, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 4, 2018
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3110
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files